KR20030030882A - 흡수성을 향상시킨 경구투여 제제 - Google Patents

흡수성을 향상시킨 경구투여 제제 Download PDF

Info

Publication number
KR20030030882A
KR20030030882A KR1020020060903A KR20020060903A KR20030030882A KR 20030030882 A KR20030030882 A KR 20030030882A KR 1020020060903 A KR1020020060903 A KR 1020020060903A KR 20020060903 A KR20020060903 A KR 20020060903A KR 20030030882 A KR20030030882 A KR 20030030882A
Authority
KR
South Korea
Prior art keywords
vitamin
tocopherol
bisbentiamine
acid
hepronicate
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
KR1020020060903A
Other languages
English (en)
Korean (ko)
Inventor
오카다미노루
스가타하루오
호리에토시아키
카네코테츠오
Original Assignee
에스에스 세야쿠 가부시키 가이샤
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 에스에스 세야쿠 가부시키 가이샤 filed Critical 에스에스 세야쿠 가부시키 가이샤
Publication of KR20030030882A publication Critical patent/KR20030030882A/ko
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • A61K31/353—3,4-Dihydrobenzopyrans, e.g. chroman, catechin
    • A61K31/355—Tocopherols, e.g. vitamin E
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
    • A61K31/444—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a six-membered ring with nitrogen as a ring heteroatom, e.g. amrinone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/506—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim not condensed and containing further heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
KR1020020060903A 2001-10-11 2002-10-07 흡수성을 향상시킨 경구투여 제제 Ceased KR20030030882A (ko)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2001313977A JP2003119141A (ja) 2001-10-11 2001-10-11 吸収性を向上した経口投与製剤
JPJP-P-2001-00313977 2001-10-11

Publications (1)

Publication Number Publication Date
KR20030030882A true KR20030030882A (ko) 2003-04-18

Family

ID=19132362

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1020020060903A Ceased KR20030030882A (ko) 2001-10-11 2002-10-07 흡수성을 향상시킨 경구투여 제제

Country Status (4)

Country Link
JP (1) JP2003119141A (enExample)
KR (1) KR20030030882A (enExample)
CN (1) CN1219514C (enExample)
TW (1) TWI244921B (enExample)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4780907B2 (ja) * 2003-09-30 2011-09-28 小林製薬株式会社 催眠剤組成物
JP4721631B2 (ja) * 2003-09-30 2011-07-13 小林製薬株式会社 催眠剤組成物
JP5094899B2 (ja) * 2010-03-23 2012-12-12 小林製薬株式会社 催眠剤組成物

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS61151132A (ja) * 1984-12-24 1986-07-09 Kanebo Ltd ビタミンｋ↓２経口剤の製造法
JPS63310827A (ja) * 1987-06-15 1988-12-19 Sanwa Kagaku Kenkyusho Co Ltd ニコチン酸誘導体を主剤とする徐放性製剤
JPH10130171A (ja) * 1996-09-04 1998-05-19 Dot:Kk 経口投与用医薬組成物
US6197328B1 (en) * 1999-08-20 2001-03-06 Dott Research Laboratory Nasally administrable compositions

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS61151132A (ja) * 1984-12-24 1986-07-09 Kanebo Ltd ビタミンｋ↓２経口剤の製造法
JPS63310827A (ja) * 1987-06-15 1988-12-19 Sanwa Kagaku Kenkyusho Co Ltd ニコチン酸誘導体を主剤とする徐放性製剤
JPH10130171A (ja) * 1996-09-04 1998-05-19 Dot:Kk 経口投与用医薬組成物
US6197328B1 (en) * 1999-08-20 2001-03-06 Dott Research Laboratory Nasally administrable compositions

Also Published As

Publication number Publication date
CN1219514C (zh) 2005-09-21
CN1411812A (zh) 2003-04-23
HK1054695A1 (en) 2003-12-12
TWI244921B (en) 2005-12-11
JP2003119141A (ja) 2003-04-23

Similar Documents

Publication Publication Date Title
TWI429405B (zh) 用於靜脈營養療法的小兒胺基酸溶液
US7060263B2 (en) Super absorption Coenzyme Q10
US9271521B2 (en) Inhibitor for liver cancer onset and progress
Blatt et al. Re-evaluation of the relative potency of synthetic and natural α-tocopherol: experimental and clinical observations
CA2499199A1 (en) Leucine-enriched nutritional compositions
CN113993546A (zh) 使用葫芦巴碱和维生素预防或治疗骨骼肌病症或障碍的组合物和方法
EP1541141A1 (en) Therapeutic agent for hepatic disease
EP1083915B1 (en) Compositions comprising molybdenum for enhancing protein anabolism and detoxification
TW200812594A (en) Medicine for prevention of and/or recovery from fatigue
JPH10287560A (ja) 医薬組成物
US20070197647A1 (en) Inhibitor for the onset and progress of liver cancer to be used in hepatitis c virus-positive human liver cirrhosis patients
JP3908513B2 (ja) 肝機能改善剤
KR20030030882A (ko) 흡수성을 향상시킨 경구투여 제제
JP5961034B2 (ja) 安定化方法
Conde et al. Relative and combined roles of ethanol and protein malnutrition on skeletal muscle
WO2011013138A1 (en) Stable multi- vitamin formulations
JP2000515874A (ja) アミノ酸組成物、ならびに腫瘍の成長および転移の処置におけるその使用
JPH09110686A (ja) マクロファージ一酸化窒素産生亢進剤
RU2698396C1 (ru) Фармацевтическая композиция для парентерального капельного введения
US20080095865A1 (en) Composition and method for increasing lean muscle mass, decreasing muscle loss, increasing muscle strength and improving athletic performance
AT412381B (de) Kombinations-präparat, enthaltend mineralstoffe, vitamine, kohlenhydrate und aminosäuren
JP5114394B2 (ja) 疲労回復のための医薬
EP3316700A1 (en) Marine peptides and muscle health
HK1054695B (en) Oral administration preparation improved in absorbability
JPH06247876A (ja) アルコール性肝障害軽減剤

Legal Events

Date Code Title Description
PA0109 Patent application

Patent event code: PA01091R01D

Comment text: Patent Application

Patent event date: 20021007

PG1501 Laying open of application
A201 Request for examination
PA0201 Request for examination

Patent event code: PA02012R01D

Patent event date: 20070912

Comment text: Request for Examination of Application

Patent event code: PA02011R01I

Patent event date: 20021007

Comment text: Patent Application

E902 Notification of reason for refusal
PE0902 Notice of grounds for rejection

Comment text: Notification of reason for refusal

Patent event date: 20090223

Patent event code: PE09021S01D

E601 Decision to refuse application
PE0601 Decision on rejection of patent

Patent event date: 20090504

Comment text: Decision to Refuse Application

Patent event code: PE06012S01D

Patent event date: 20090223

Comment text: Notification of reason for refusal

Patent event code: PE06011S01I